Literature DB >> 17597166

The neuropsychological basis of hypersociability in Williams and Down syndrome.

Melanie A Porter1, Max Coltheart, Robyn Langdon.   

Abstract

People with Williams syndrome (WS) display indiscriminate approach toward strangers in everyday life. People with Down syndrome (DS) can also do so, but to a lesser degree. Inappropriate approach behavior is also characteristic of people with acquired amygdala damage and people with acquired frontal lobe impairment; given this, the developmental disorder of social approach seen in WS and perhaps also DS might be due to poor emotion recognition (due to abnormal amygdala functioning) or poor control of behavior (due to frontal lobe abnormality). A third account of this developmental disorder of social cognition can be couched in terms of heightened salience for social stimuli. We explored these three hypotheses by testing emotion recognition, social approach and frontal lobe functioning in people with WS and DS. Overall, our results were inconsistent with predictions from the amygdala and social salience hypotheses. In contrast, results from a battery of neuropsychological tasks suggested that abnormal social approach in WS and DS in everyday life is best explained by frontal lobe impairment, in particular, poor response inhibition.

Entities:  

Mesh:

Year:  2007        PMID: 17597166     DOI: 10.1016/j.neuropsychologia.2007.05.006

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  69 in total

1.  Emotion recognition and visual-scan paths in Fragile X syndrome.

Authors:  Tracey A Shaw; Melanie A Porter
Journal:  J Autism Dev Disord       Date:  2013-05

2.  Relations between social-perceptual ability in multi- and unisensory contexts, autonomic reactivity, and social functioning in individuals with Williams syndrome.

Authors:  Anna Järvinen; Rowena Ng; Davide Crivelli; Andrew J Arnold; Nicholas Woo-VonHoogenstyn; Ursula Bellugi
Journal:  Neuropsychologia       Date:  2015-05-19       Impact factor: 3.139

3.  Brief Report: Contrasting Profiles of Everyday Executive Functioning in Smith-Magenis Syndrome and Down Syndrome.

Authors:  Lucy Wilde; Chris Oliver
Journal:  J Autism Dev Disord       Date:  2017-08

4.  Frontal asymmetry index in Williams syndrome: Evidence for altered emotional brain circuitry?

Authors:  Rowena Ng; Inna Fishman; Ursula Bellugi
Journal:  Soc Neurosci       Date:  2015-01-29       Impact factor: 2.083

5.  Using novel control groups to dissect the amygdala's role in Williams syndrome.

Authors:  Tricia A Thornton-Wells; Suzanne N Avery; Jennifer Urbano Blackford
Journal:  Dev Cogn Neurosci       Date:  2011-07       Impact factor: 6.464

6.  Affiliative behavior in Williams syndrome: social perception and real-life social behavior.

Authors:  Anna Järvinen-Pasley; Ralph Adolphs; Anna Yam; Kiley J Hill; Mark Grichanik; Judy Reilly; Debra Mills; Allan L Reiss; Julie R Korenberg; Ursula Bellugi
Journal:  Neuropsychologia       Date:  2010-04-10       Impact factor: 3.139

7.  Genetic influences on sociability: heightened amygdala reactivity and event-related responses to positive social stimuli in Williams syndrome.

Authors:  Brian W Haas; Debra Mills; Anna Yam; Fumiko Hoeft; Ursula Bellugi; Allan Reiss
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

8.  Cognitive and social profiles in two patients with cobalamin C disease.

Authors:  M H Beauchamp; V Anderson; A Boneh
Journal:  J Inherit Metab Dis       Date:  2009-10-15       Impact factor: 4.982

9.  Do faces capture the attention of individuals with Williams syndrome or autism? Evidence from tracking eye movements.

Authors:  Deborah M Riby; Peter J B Hancock
Journal:  J Autism Dev Disord       Date:  2008-09-12

10.  Autonomic responses to dynamic displays of facial expressions in adolescents and adults with Williams syndrome.

Authors:  D Plesa Skwerer; L Borum; A Verbalis; C Schofield; N Crawford; L Ciciolla; H Tager-Flusberg
Journal:  Soc Cogn Affect Neurosci       Date:  2008-11-30       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.